Sleep as an Active Modifier of Blood-Based Biomarkers in Alzheimer’s Disease
Author:
Open Access
- 31 March 2026
- journal article
- Published by Korean Society of Sleep Medicine in Sleep Medicine Research
- Vol. 17 (1) , 1-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Associations of Sleep Quality and Apolipoprotein Genotype with Blood‐based Biomarkers of Alzheimer's Disease and NeurodegenerationAlzheimer's & Dementia, 2025
- The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s diseaseTranslational Neurodegeneration, 2023
- The association of obstructive sleep apnea with blood and cerebrospinal fluid biomarkers of Alzheimer’s dementia - A systematic review and meta-analysisSleep Medicine Reviews, 2023
- Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkersAlzheimer's & Dementia, 2023
- The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humansScience, 2019
- Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?Trends in Neurosciences, 2016
- The Blood-Brain BarrierThe Neuroscientist, 2016
- Sleep and Alzheimer disease pathology—a bidirectional relationshipNature Reviews Neurology, 2013